Why the study?
The incidence of cardiovascular diseases and their associated risk factors increasingly impact population health in China, requiring updated epidemiological, clinical, and health economic data to inform prevention, control, and public health policy.
Cross-Sectional (n=199,684)
Multi-stage stratified cluster random sampling
Yes
This national report provides updated epidemiological data on cardiovascular and cerebrovascular disease incidence (639.46 per 100,000) and tobacco use prevalence (23.2%) in China to guide public health policy and cardiovascular prevention strategies.
Answers are grounded in this paper and cite their sources.
Modest smoking decline supports sustained tobacco control in China; leaves open links to cardiovascular incidence trends.
The incidence of cardiovascular diseases (CVD) together with their associated risk factors increasingly impact population health. According to the data provided in the 2025 Annual Report on Cardiovascular Diseases in China, the crude incidence of cardiovascular and cerebrovascular diseases among Chinese residents aged ≥18 years, including acute myocardial infarction (AMI), angina pectoris treated by percutaneous transluminal coronary angioplasty/stent implantation and/or coronary artery bypass grafting, stroke, and sudden cardiac death was 639.46 per 100,000 (age-standardized incidence rate: 651.47 per 100,000). Crude AMI incidence was 91.47 per 100,000. Crude stoke incidence was 499.78 per 100,000. In addition to interpreting the key findings of CVD incidence and mortality in China, we provide updated data on associated risk factors, including tobacco use, diet and nutrition, physical activity, overweight and obesity, hypertension, dyslipidemia, diabetes, chronic kidney disease, sleep and mental health, and environmental factors. Statistics on diagnosis and treatment of CVD diseases, updates on CVD research and health economic studies of CVD provide a scientific foundation for advancing CVD prevention and control, as well as for informing relevant public health policy development.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted a cross-sectional in Tobacco use and secondhand smoke exposure (n=199,684). Tobacco control policies and tobacco use surveillance (2024 survey wave) vs. 2022 China Adult Tobacco Survey wave was evaluated on Current smoking prevalence among individuals aged 15 years and older (ARR 0.9 percentage points).
Synapse has enriched 10 related papers. Consider them for comparative context: